PathoNostics offers multiplex real-time PCR assays for the diagnosis of superficial and invasive fungal infections as well as the identification of multi-azole resistance. Our assays advance the diagnosis of fungal infections and allow antifungal therapy to be more appropriately targeted. Currently 3 products are available: AsperGenius®, DermaGenius®, and PneumoGenius®.

PathoNostics

100% score for QCMD 2016 DermaGenius

Wednesday, January 11, 2017 – The DermaGenius assay scored 100% with the 2016 Dermatophytosis EQA Pilot Study. The report is available upon request.